×
  • Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
 

Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder

by Presidente del Consejo Superior de Sanidad at Hospital Universitario 12 de Octubre on Jul 22, 2013

  • 472 views

Yes-associated protein 1 (YAP 1), the nuclear effector of the Hippo pathway, is a key regulator of organ size and a candidate human oncogene in multiple tumors. However, the expression dynamics of YAP ...

Yes-associated protein 1 (YAP 1), the nuclear effector of the Hippo pathway, is a key regulator of organ size and a candidate human oncogene in multiple tumors. However, the expression dynamics of YAP 1 in urothelial carcinoma of the bladder (UCB) and its clinical/prognostic significance are unclear.

Statistics

Views

Total Views
472
Views on SlideShare
229
Embed Views
243

Actions

Likes
0
Downloads
0
Comments
0

2 Embeds 243

http://enriquemorenogonzalez.es 174
http://enriquemorenogonzalez.com 69

Accessibility

Upload Details

Uploaded via SlideShare as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
Post Comment
Edit your comment

Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder Document Transcript